STXS
STXS
AMEX · Health Care

Stereotaxis Inc

$0.85
-0.05 (-5.56%)
As of Nov 14, 2:19 AM ET ·
Financial Highlights (FY 2026)
Revenue
35.76M
Net Income
-23,899,797
Gross Margin
52.7%
Profit Margin
-66.9%
Rev Growth
+4.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 52.7% 52.7% 28.9% 28.9%
Operating Margin -69.8% -62.8% 17.9% 17.4%
Profit Margin -66.9% -63.5% 17.6% 14.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 35.76M 34.14M 48.26M 53.66M
Gross Profit 18.86M 18.00M 13.94M 15.50M
Operating Income -24,967,060 -21,447,316 8.66M 9.35M
Net Income -23,899,797 -20,530,511 8.48M 7.97M
Gross Margin 52.7% 52.7% 28.9% 28.9%
Operating Margin -69.8% -62.8% 17.9% 17.4%
Profit Margin -66.9% -63.5% 17.6% 14.9%
Rev Growth +4.8% +4.8% -8.7% +18.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 84.62M 80.81M
Total Equity — — 87.10M 96.45M
D/E Ratio — — 0.97 0.84
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -24,271,505 -22,008,141 11.74M 13.85M
Free Cash Flow — — 4.58M 4.02M